Pharming Group N.V.

PHAR ·Healthcare, Drug Manufacturers - General, Netherlands
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $500.0M

Liabilities Breakdown FY2025

Total Liabilities: $222.9M